Elodie Jacqueroux

Pharmacological characterization of the 3D MucilAir™ nasal model

Clément Mercier, Elodie Jacqueroux, Zhiguo Hé et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 53 citations · Full text

Molecular Pharmacology, Medicine, Drug Discovery +4

In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition

Sophie Hodin, Thierry Basset, Elodie Jacqueroux et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2017 · 52 citations

Breast Oncology, Oncology, Health Sciences +10

In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein

V. Margelidon-Cozzolino, Sophie Hodin, Elodie Jacqueroux et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 25 citations · Full text

In vitro assessment of P‐gp and BCRP transporter‐mediated drug–drug interactions of riociguat with direct oral anticoagulants

Elodie Jacqueroux, Clément Mercier, V. Margelidon-Cozzolino et al. · Fundamental and Clinical Pharmacology · 2019 · 22 citations

Pharmaceutical Science, Direct Oral Anticoagulants, Pharmacotherapy +22

Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban

Elodie Jacqueroux, Sophie Hodin, Sonia Saïb et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2020 · 11 citations · Full text

Transporter-mediated Drug-drug Interactions, Abc Transporters, Biochemistry +10